Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,969
+$15,181 QoQ
Shares Held
3,634
+434.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#132
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,518 across 427 Biotechnology names. CCCC ranks #243 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,969 | 3,634 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,788 | 680 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,281 | 671 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $405,460 | 182,640 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $341,707 | 238,957 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $8,902 | 5,565 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $29,231 | 8,120 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $35,937 | 6,305 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $32,607 | 7,058 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $194,853 | 23,850 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $3,067 | 543 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,794 | 5,804 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,539 | 560 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,208 | 2,933 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $48,886 | 8,286 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,269 | 1,057 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,880 | 780 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $59,581 | 2,456 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $369,494 | 11,475 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $340,683 | 7,625 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $195,896 | 5,177 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $33,475 | 905 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $33,891 | 1,023 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||